This statistic shows the annual revenue of Danish biotechnology company Genmab from 2009 to 2024. The revenue was increasing annually from 2013 to 2020. After a significant drop in 2021, revenue growth was very strong in the following years. Revenues peaked in 2024 at around 21.5 billion Danish kroner.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Genmab, & Nasdaq Nordic. (February 12, 2025). Revenue of Genmab from 2009 to 2024 (in million DKK) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 25, 2026, from /statistics/970390/revenue-of-genmab/
Genmab, und Nasdaq Nordic. "Revenue of Genmab from 2009 to 2024 (in million DKK) ." Chart. February 12, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 25, 2026. /statistics/970390/revenue-of-genmab/
Genmab, Nasdaq Nordic. (2025). Revenue of Genmab from 2009 to 2024 (in million DKK) . ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 25, 2026. /statistics/970390/revenue-of-genmab/
Genmab, and Nasdaq Nordic. "Revenue of Genmab from 2009 to 2024 (in Million Dkk) ." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 12 Feb 2025, /statistics/970390/revenue-of-genmab/
Genmab & Nasdaq Nordic, Revenue of Genmab from 2009 to 2024 (in million DKK) ÌÇÐÄÆƽâ°æ, /statistics/970390/revenue-of-genmab/ (last visited July 25, 2026)
Revenue of Genmab from 2009 to 2024 (in million DKK) [Graph], Genmab, & Nasdaq Nordic, February 12, 2025. [Online]. Available: /statistics/970390/revenue-of-genmab/
